Search


Singapore's HSA: Post-Industry Consultation Updates on eCTD Implementation in Singapore
On 11th December 2023, Singapore's Health Sciences Authority (HSA) released an update "Post-Industry Consultation Updates on Electronic...
Sharan Murugan
Dec 11, 20231 min read
29 views
0 comments


Singapore's HSA: Regulatory Updates for Therapeutic Product Registration
On 30th June 2023, Singapore's Health Sciences Authority (HSA) released updated guidance on "Regulatory Updates for Therapeutic Product...
Sharan Murugan
Jul 1, 20231 min read
94 views
0 comments


Singapore's HSA: Consultation on eCTD Implementation & Risk Classification on IVD
On 2nd May, 2023 Singapore's Health Sciences Authority (HSA) invited the industry to participate in the consultation on eCTD submissions...
Sharan Murugan
May 4, 20231 min read
132 views
0 comments


Singapore HSA MedDev: Regulatory Guidelines for Laboratory Developed Tests (LDTs)
On 22nd November, 2022 Singapore's Health Sciences Authority released the final Regulatory Guidelines for Laboratory Developed Tests...
Sharan Murugan
Nov 27, 20221 min read
30 views
0 comments


Singapore HSA: Safety Alert for Finasteride and Potential Risk of Suicidal iIdeation
The Singapore Health Sciences Authority (HSA) published a Safety Alert for Finasteride on 30-August-2022. Suicidal ideation is a known...
Sharan Murugan
Sep 1, 20221 min read
25 views
0 comments


Guidance documents for Therapeutic Products
Health Sciences Authority (HSA) updated its "GUIDANCE ON THERAPEUTIC PRODUCT REGISTRATION IN SINGAPORE" recently, which describes the...
Sharan Murugan
Jun 13, 20221 min read
53 views
0 comments


Guidance documents for Therapeutic Products (e-labelling) – SINGAPORE
The Therapeutic Products Branch (TPB) finalized guidance on e-labelling of therapeutic products (TPs) in Singapore has been published and...
Sharan Murugan
May 8, 20211 min read
74 views
0 comments